MedTrace Logo

Study Comparing One Versus Two Cortisone Injections for Trigger Finger

NCT00951236 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 392

Last updated 2014-02-12

No results posted yet for this study

Summary

Trigger finger, also known as stenosing tenosynovitis, is a painful condition that can cause discomfort and disability. Many physicians choose to locally inject cortisone into the infected finger although there is no current consensus as to how many injections are needed to achieve maximum relief. This study will be a prospective, randomized study to compare one versus two injections for the treatment of trigger finger.

Conditions

  • Stenosing Tenosynovitis
  • Trigger Finger

Interventions

DRUG

One cortisone injection

Patients in this arm will receive one cortisone injection for the treatment of his/her symptoms

DRUG

Two cortisone Injections

Subjects randomized to this treatment will receive two cortisone injections, 4-6 weeks apart

Sponsors & Collaborators

  • Rothman Institute Orthopaedics

    lead OTHER

Principal Investigators

  • Charles Leinberry, MD · Rothman Institute

  • Pedro Beredjiklian, MD · Rothman Institute

  • Emran Sheikh, MD · Rothman Institute

Study Design

Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00951236 on ClinicalTrials.gov